Recent developments in dosage form design are discussed from the viewpoint that there are three key objectives in formulation; optimum biological availability, minimum side effects and maximum patient compliance. The pilocarpine Ocusert device (Alza) and the talampicillin prodrug (Beechams) are taken as examples of a physical and chemical approach to rational drug delivery.
No takes yet. Share an insight, caveat, or question.
Stanley S. Davis (1976) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: